1-3 of 3
Nitin Chakravarti
Close
Sort by
Journal Articles

Preclinical evaluation of anti-CD38 therapy in mature T-cell neoplasms

Colleen Isabelle, William T. Johnson, Kathleen McConnell, Ashley Vogel, Jonathan E. Brammer, Amy Boles, Robyn Keller, Paola Sindaco, Liam Nisenfeld, Guldeep Uppal, Neda Nikbakht, Bruno Calabretta, Patrizia Porazzi, Jerald Gong, Nitin Chakravarti, Pierluigi Porcu, Anjali Mishra
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3637–3641.
https://doi.org/10.1182/bloodadvances.2023009807
Published: 2023
Includes: Supplemental data
Journal Articles

Defining the AHR-regulated transcriptome in NK cells reveals gene expression programs relevant to development and function

Prashant Trikha, Jena E. Moseman, Aarohi Thakkar, Amanda R. Campbell, Ezgi Elmas, Jennifer A. Foltz, Nitin Chakravarti, James R. Fitch, Elaine R. Mardis, Dean A. Lee
Journal: Blood Advances
Blood Adv (2021) 5 (22): 4605–4618.
https://doi.org/10.1182/bloodadvances.2021004533
Published: 2021
Includes: Supplemental data
Journal Articles

Highly cytotoxic natural killer cells are associated with poor prognosis in patients with cutaneous T-cell lymphoma

Bethany Mundy-Bosse, Nathan Denlinger, Eric McLaughlin, Nitin Chakravarti, Susan Hwang, Li Chen, Hsiaoyin Charlene Mao, David Kline, Youssef Youssef, Rebecca Kohnken, Dean Anthony Lee, Gerard Lozanski, Aharon G. Freud, Pierluigi Porcu, Basem William, Michael A. Caligiuri, Anjali Mishra
Journal: Blood Advances
Blood Adv (2018) 2 (15): 1818–1827.
https://doi.org/10.1182/bloodadvances.2018020388
Published: 2018
Includes: Supplemental data